PSM's 4th annual Interchange conference was held October 24, 2013 at the Knight Conference Center at The Newseum, 555 Pennsylvania Av., NW, Washington, D.C..

 

 

Keynote Speaker: Dr. Ilisa Bernstein, Deputy Director of the Office of Compliance in the Center for Drug Evaluation and Research (FDA)

Each year, the PSM Interchange brings together policymakers, pharmaceutical manufacturers, patient advocates, law enforcement, healthcare professionals, and anti-counterfeiting companies to discuss the problem and solutions to the global scourge of pharmaceutical counterfeiting.

Counterfeit Drugs Infographic Slide Presentation

7:30 a.m. - 8:30 a.m. Pre-conference breakfast, sponsor table browsing and networking.

8:30 a.m. - Conference opener

  • Introduction - Scott LaGanga, Executive Director Partnership for Safe Medicines;
    Senior Vice President, Public Affairs - Advocacy, Pharmaceutical Research and Manufacturers of America (PhRMA)
    Slide Presentation
    Watch Video

8:40 a.m. - 9:10 a.m. Research Presentations

  • Tim K. Mackey, PhD, Assistant Professor, University of California, School of Medicine, Department of Anesthesiology - Clear and Present Danger: Availability of Dangerous, Unapproved and Recalled Drugs Online.
    Slide Presentation
    Watch Video
  • Marv Shepherd, PhD, Director, Center for Pharmacoeconomic Studies, College of Pharmacy, University of Texas.Grey Market Vendor Activities and Drug Shortages in Texas Acute Care Hospitals. Grey market medicine purchases have been associated with hoarding, price gouging and safety issues. Learn more about hospitals purchasing medication from the grey market.
    Slide Presentation
    Watch Video

9:10 – 10:30 a.m. Panel 1: How Have American Patients Been Impacted by Counterfeit Medicines?

  • Moderator: Scott Williams, Director, American Cancer Society Cancer Action Network
    Moderator will provide 20 minute overview of the ways patient consequences of counterfeit and non-FDA approved medicines found in circulation in 2012-2013. Among the topics covered will be Avastin, osteoporosis drugs, Botox, Adderall, stolen goods re-sold into legitimate pharmacies, fake online pharmacies, myths and lies that convince consumers to purchase from non-FDA approved sources. Panel discussion to focus on the major ways patient groups have been impacted by these events.
    Slide Presentation
    Watch Video

Panelists:

  • William E. Arnold, CEO and Vice-Chair, Community Access National Network (PSM member)
  • Christopher Weaver, Health & Science Reporter, The Wall Street Journal
  • Suzanne Willard, President-Elect, Association of Nurses in AIDS Care (PSM member)

10:30 a.m. - 10:45 a.m. Networking Break

10:45 a.m. - 12:05 p.m. Panel 2: Overview of Fake Online Pharmacy Issues

  • Moderator: Dr. Bryan Liang, Professor of Anesthesiology
    Director, San Diego Center for Patient Safety, University of California, San Diego School of Medicine
    Medical Director, Program on Health Policy & Law, University of California, San Diego
    Moderator will provide 20 minute overview of the current status of fake online pharmacies - influence of social media, ease of creation, depth of organized crime involvement, linked to health risks caused by fake medications. Discuss FDA warnings to websites for selling counterfeit and mis-branded medications and the patient safety risks. Panel discussion to focus on the various risks involved from fake online pharmacies.
    Slide Presentation
    Watch Video

Panelists:

  • Amelia Arnold, Pharm.D., Clinical Pharmacist, Community Pharmacies, Maine
  • Special Agent Daniel Burke, Senior Operations Manager in Charge of Cybercrime Investigations for FDA-OCI
  • Gg Levine, Policy and Communications Project Manager, National Association of Boards of Pharmacy

12:05 p.m. - 1:15 p.m. Luncheon

1:15 p.m. - 2:35 p.m. Panel 3: Bringing Criminals to Justice Across Jurisdictions

  • Moderator: Chuck Forsaith, Corporate Director, Supply Chain Security, Purdue Pharma Technologies, Inc.
    Moderator to provide 20 minute overview of the recent history of medicine counterfeiting crime in the US. Panel to discuss recent closed cases. Watch Video

Panelists:

  • Trial Attorney Roger Gural, Department of Justice, Consumer Protection Branch Watch Video
  • Assistant US Attorney Sam Louis, Deputy Chief Program Fraud Division Watch Video
  • Andy Shuttleworth, Unit Chief, National IPR Coordination Center Watch Video

2:35 p.m. - 3:35 p.m. Panel 4: Overview of New Developments in International Cooperation

  • Moderator: Linda Marks, Senior Litigation Counsel of the Consumer Protection Branch of the U.S. Department of Justice
    Moderator to provide 15 minute overview of the impact of counterfeit medications worldwide, highlighting the impact the world counterfeiting problem has on Americans. Panel discussion will focus on new developments in international cooperation to fight counterfeit medicines.
    Slide Presentation
    Watch Video

Panelists:

  • Scott Ballman, Technical Expert for IP Program - North America, World Customs Organization
  • Dr. Patrick Lukulay, Vice President of Global Health Impact Programs at USP and Director of the USAID Promoting the Quality of Medicines Program
  • John Roth, Director U.S. Food and Drug Administration Office of Criminal Investigations

3:35 p.m. - 4:00 p.m. Keynote Speaker: Dr. Ilisa Bernstein, Deputy Director of the Office of Compliance in the Center for Drug Evaluation and Research (FDA) Watch Video

4:15 p.m. - 4:17 p.m. Closing Remarks - Scott LaGanga

4:17 p.m. - 5:15 p.m. Reception

Note: Agenda subject to change